The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Dalacin C 150 mg Hard Capsules



Pfizer Healthcare IrelandPA0822/120/001

Main Information

Trade NameDalacin C 150 mg Hard Capsules
Active SubstancesClindamycin
Dosage FormCapsule, hard
Licence HolderPfizer Healthcare Ireland
Licence NumberPA0822/120/001

Group Information

ATC CodeJ01FF Lincosamides
J01FF01 clindamycin

Status

License statusAuthorised
Licence Issued10/05/1977
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceNone.
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back